Martin, Elizabeth
Schulz, Kurt P.
Hildebrandt, Tom
Sysko, Robyn
Berner, Laura A. https://orcid.org/0000-0002-1430-8028
Li, Xiaobo https://orcid.org/0000-0002-8153-5415
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH126448)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH126448)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH126448)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH126448)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH126448)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH126448)
Article History
Received: 12 March 2025
Revised: 28 October 2025
Accepted: 7 November 2025
First Online: 22 November 2025
Competing interests
: Dr. Hildebrandt is a scientific advisory board member of Noom. Drs. Hildebrandt and Sysko receive funding from and have equity in Noom (a non-publicly traded company). Dr. Sysko receives royalties from Wolters Kluwer Health. Dr. Berner is a scientific advisor to Juniver, Ltd. Drs. Martin, Schulz, and Li report no other financial relationships with commercial interests, or potential conflicts of interest.